Cumberland Pharmaceuticals Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
Cumberland Pharmaceuticals Inc. (CPIX) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $40.38 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-03-09
- Cumberland Pharmaceuticals Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $40.38M, a 24.32% increase from fiscal 2016.
- Cumberland Pharmaceuticals Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $32.48M, a 1.62% decline from fiscal 2015.
- Cumberland Pharmaceuticals Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $33.01M, a 10.01% decline from fiscal 2014.
- Cumberland Pharmaceuticals Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $36.68M, a 17.95% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|
| 2017-12-31 | $40.38M 10-K · filed 2018-03-09 |
| 2016-12-31 | $32.48M 10-K · filed 2018-03-09 |
| 2015-12-31 | $33.01M 10-K · filed 2018-03-09 |
| 2014-12-31 | $36.68M 10-K · filed 2017-03-13 |
| 2013-12-31 | $31.10M 10-K · filed 2016-03-14 |
| 2012-12-31 | $47.94M 10-K · filed 2015-03-09 |
| 2011-12-31 | $50.89M 10-K · filed 2014-03-11 |
| 2010-12-31 | $44.70M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |